Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- BANOS Anne, Dr
Centre Hospitalier de BAYONNE
Principal Investigator - LEBLOND Véronique, Dr
APHP PARIS
Principal Investigator - LEGOUILL Steven, Dr
Centre Hospitalier de NANTES
Principal Investigator - LELEU Xavier, Dr
CHRU LILLE
Study Director - MOREL Pierre, Dr
Centre Hospitalier de Lens
Principal Investigator - SALLES Gilles, Pr
Centre Hospitalier de LYON
Principal Investigator - TOURNILLAC Olivier, Dr
Centre Hospitalier CLERMOND FERRAND
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier de la Côte Basque
Bayonne, France
- Ch Clermond Ferrand
Clermont-Ferrand, France
- Ch Lens
Lens, France
- Chru Lille
Lille, France
- Ch Nantes
Nantes, France
- Groupe Hospitalier Pitié Salpétrière
Paris, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 31 Mar 2017
- Completion
- 30 Apr 2017
- Last update posted
- 28 Nov 2025
- Registered enrollment
- 17
- Registry id
- NCT02302469
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.